Glycogen synthase kinase (GSK) 3beta hyperactivity impairs glomerular podocyte insulin signaling via IRS1 modulation in diabetic kidney disease (Translation: The University of Toledo Journal of Medical Sciences, 2025)
Keywords: GSK3beta hyperactivity; hyperinsulinemia; diabetic kidney disease